SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-16-000076
Filing Date
2016-12-19
Accepted
2016-12-19 17:19:20
Documents
5
Period of Report
2016-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K december1920168-k.htm 8-K 36143
2 EXHIBIT 10.1 biogenemploymentagreementf.htm EX-10.1 158387
3 EXHIBIT 99.1 pressreleasedateddecember1.htm EX-99.1 15423
4 biogenlogo.jpg GRAPHIC 17556
5 biogenlogostandarda07.jpg GRAPHIC 756402
  Complete submission text file 0000875045-16-000076.txt   1256798
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 162059691
SIC: 2836 Biological Products, (No Diagnostic Substances)